✦ LIBER ✦

Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer

✍ Scribed by Gunnar Folprecht,Susanne Hamann,Katharina Schütte,Tanja Trarbach…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

664 PUBLICATION Cetuximab in combination

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

FCGR2AandFCGR3Apolymorphisms and clinica

✍ Kjersem, Janne B; Skovlund, Eva; Ikdahl, Tone; Guren, Tormod; Kersten, Christian 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 384 KB

598 ORAL Randomised comparison of 5-FU/f

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase I of CPT-11 (CAMPTO®) combined wit

✍ R. Ristamäki; B. Glimelius; T. Linné; B. Boussard; D. Oulid-Aïssa; S. Pyrhonen 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 104 KB

702 PUBLICATION Cetuximab and irinotecan

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

642 POSTER Cetuximab plus oxaliplatin/5-

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 268 KB